Bellevue HEALTHCARE TRUST plc
LEI: 213800HQ3J3H9YF2UI82
22 March 2024
Director dealings
Bellevue Healthcare Trust plc announces that the undermentioned directors of the Company sold and, following settlement, repurchased Ordinary Shares through a Bed and ISA arrangement, in order to affect the transfer of the Ordinary Shares to their respective ISA accounts.
The transactions are summarised below:
| Director | Shares sold | Shares acquired | Total holding following notification |
| Jo Dixon | 15,775 | 15,775 | 125,109 |
| Tony Young | 12,156 | 12,086 | 34,668 |
| Paul Southgate | 5,933 | 5,933 | 97,880 |
| Kate Bolsover | 5,933 | 5,892 | 28,948 |
Enquiries:
| Apex Listed Companies Services (UK) Limited | +44 20 3327 9720 |
| Company Secretary | |
| | |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Josephine Dixon | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 15,775 shares and repurchase of 15,775 shares | ||||
| c)
| Price(s) and volume(s) |
| | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale)
Transaction 2 (sale)
Transaction 3 (purchase)
| | 146.375p per share 146.3758p per share
146.6817p per share | 3,686 12,089
15,775 | | ||
| | | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume
| Sale: 15,775 | |||||
| | | |||||
| - Price | Total price sale: £23,090.75 | |||||
| | | |||||
| e)
| Date of the transaction
| 19 March 2024 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Tony Young | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 12,156 shares and repurchase of 12,086 shares | ||||
| c)
| Price(s) and volume(s)
| | | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale)
Transaction 2 (purchase)
| | 149.7p per share
149.7p per share | 12,156
12,086 | | ||
| | | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume | Sale: 12,156 | |||||
| | | |||||
| - Price | Total price sale: £18,197.53 | |||||
| | | |||||
| e)
| Date of the transaction
| 21 March 2024 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Paul Southgate | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 5,933 shares and repurchase of 5,933 shares | ||||
| c)
| Price(s) and volume(s)
| | | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale)
Transaction 2 (purchase)
| | 146.4493p per share
146.679p per share | 5,933
5,933 | | ||
| | | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume | Sale: 5,933 | |||||
| | | |||||
| - Price | Total price sale: £8,688.84 | |||||
| | | |||||
| e)
| Date of the transaction
| 19 March 2024 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Kate Bolsover | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 5,933 Ordinary Shares and repurchase of 5,892 Ordinary Shares | ||||
| c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale) | | 147.4p per share | 5,933 | | ||
| | | | | | ||
| Transaction 2 (purchase) | | 147.4p per share | 5,892 | | ||
|
| | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume | Sale: 5,933 shares Purchase: 5,892
| |||||
| - Price | Total price sale: £8,745.24 Total price purchase: £8,684.81
| |||||
| | | |||||
| e)
| Date of the transaction
| 20 March 2024 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
